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Electrical charge of serum and urinary albumin in normal and diabetic
humans. The isoelectric points of albumin purified by pseudo-ligand
chromatography on Affi-Gel Blue were determined simultaneously in
serum and urine of 11 normal subjects and 25 diabetic patients,
subdivided in groups according to their urinary excretion rates of
albumin. Serum albumin was consituted by a single homogeneous peak
at 4.7 (p1) in normal subjects, whereas the levels for diabetic patients
covered this band and some other microheterogeneous levels, ranging
from 3.5 to 7 p1. By affinity chromatography with Concanavalin
A-Sepharose and immunoelectrophoretic techniques, all these micro-
heterogeneous bands were characterized as glycosyl albumin. In nor-
mal subjects and diabetic patients whose urinary excretion rate of
albumin was normal or increased only slightly (10 to 100 .gImin), the
pattern of urinary albumin included a main band with normal p1(4.7)
and some remarkable amounts of more anionic bands (p1 between 4.0
and 4.7) if compared to the native protein, which was characterized as
glycosyl albumin. Such a difference was not detected in urines of
diabetic patients with clinical nephropathy. These results indicate that
the non-enzymatic glycosylation of albumin is a main determinant of the
excretion of this protein into urine, in spite of the anionic electrical
charge. We describe also the renal selectivity properties in humans that
may be viewed as a model for the study of renal disease, but the role of
such a mechanism in early diabetic nephropathy remains unknown.
Charge electrique de l'albumine serique et urinaire chez des hommes
normaux et diabétiques. Les points isodctriques de l'albumine purifiée
par chromatographie avec pseudo-ligand sur Affi-Gel Blue ont été
déterminés simultanément dans le serum et les urines de 11 sujets
normaux et de 25 malades diabétiques subdivisds selon leur debit
d'excrétion urinaire d'albumine. L'albumine sérique était sous forme
d'un pic homogene unique a 4,7 (p1) chez les sujets normaux, tandis
qu'en plus de cette bande principale, d'autres, microheterogenes,
couvrant une large zone de p1 de 3,5 7, dtaient détectées dans le serum
des malades diabetiques. Par des techniques de chromatographie d'af-
finite avec du Sepharose-Concanavaline A et d'immunoClectrophorCse,
toutes ces bands microheterogenes ont dté caractérisées comme etant
de l'albumine glycosylée. Chez les sujets normaux et chez les
diabetiques dont le debit d'excrétion urinaire d'albumine était normal
ou seulement un peu élevé (10 a 100 g/min), l'aspect de l'albumine
urinaire comportait une bande principale de p1 normal (4,7) et quelques
bandes discernables plus anioniques (p1 entre 4,0 et 4,7), par rapport a
Ia protéine native caractérisée comme de l'albumine glycosilee. Une
telle difference n'était pas détectée dans les urines des diabCtiques
atteints d'une néphropathie clinique. Ces résultats indiquent que Ia
glycosylation non enzymatique de l'albumine est un determinant es-
sentiel de l'excrétion de cette protéine dans les urines, malgré une
charge electrique anionique, et ils dCcrivent les propriCtCs de sClectivitC
rdnale chez les étres vivants, qui peuvent être pris comme modèle
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d'étude des maladies rénales. La contribution d'un tel mdcanisme lors
de la nephropathie diabétique debutante reste a élucider.
While a heavy proteinuria is the hallmark of the full-blown
picture of diabetic glomerulopathy, a moderate increase in
urinary albumin excretion (UAE) may appear very early in the
course of diabetes mellitus as a herald of renal involvement [1,
2]. Indeed, it is early albuminuria that offers the first indication
of diabetic nephropathy (UAE of 10 to 100 jig/mm) and that has
been incriminated in the pathogenesis of the late nephropathy.
According to some authors [3, 41, in fact, the accumulation of
proteic material within the mesangium would stimulate the
glomerular sclerosis and the progression toward renal failure.
The observation that arterial hypertension accelerates the
evolution of renal lesions in diabetic patients [5] and in rats [6,
7] points to a determinant role of hemodynamic factors; how-
ever, these data suggest also that, besides the hemodynamic
perturbation, diabetes is an essential prerequisite to the devel-
opment of the glomerular lesions [6, 7]. In addition to hemody-
namic factors, alterations in size and charge selectivity proper-
ties of the glomerular membrane have been considered as
possible mechanisms responsible for albumin hyperfiltration. In
fact, recent studies [8] have shown, during the clinically overt
phase of diabetic nephropathy, variations in porosity of the
glomerular wall, which can explain the proteinuria. At earlier
stages, however, in spite of reported reductions in sialic acid [9]
and glycosaminoglycans [10] content of the glomerular basal
membrane, clearance studies using both neutral [11, 121 and
anionic dextrans [13] failed to provide evidence for either an
increase of glomerular porosity or an alteration of the electrical
properties of the glomerular wall [11—13].
There is now an increasing body of evidence pointing to a
molecular mechanism as being responsible for albuminuria.
This is based on the observation that the renal handling of
glycosyl albumin (GA) is increased when compared with that of
normal albumin [14], and that GA is ingested avidly by endo-
thelial cells of isolated microvessels [15]. Furthermore, the
structural analysis of GA has shown that the process of non-
enzymatic glycosylation may induce the formation of anionic as
well as cationic bands of albumin [14, 16]. Therefore, in
agreement with modern concepts on renal filtration of macro-
molecules, it seems likely that in addition to hemodynamic
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Fig. 1. isoeleciric focusing patterns of serum albumin in ten diabetic patients of Group B. Albumin was purified from sera by pseudo-ligand affinity
chromatography on Affi-Gel Blue. Ultrathin IEF was carried out in a linear range of Ampholine between 3.5 and 9.5 (silver stained). One hundred
g of each sample was applied to the gel. In position a, a sample of low glycosylated albumin was run.
factors the electrical charge of GA could be a determinant of its
accelerated passage.
Methods
Patients
The study was performed in 11 normal subjects (five women,
six men), ranging in age from 21 to 52 years (mean 31.5) and 25
Type I diabetic patients (11 women, 14 men) [171, ranging in age
from 9 to 53 years (mean 42). Age was not significantly different
between normal and diabetic subjects. Normal subjects were
healthy, normotensive, and without signs of nephropathy. They
were not receiving any medication and were on a diet contain-
ing 30 to 35 Kcal, 0.7 to 0.85 g protein/kg body wt, and 4 g NaC1.
The diabetic population was subdivided into three groups
according to UAE: Group A, nine patients with UAE < 10
j.g/min; Group B, 11 patients with UAE between 10 and 100
ig/min; and Group C, five patients with UAE> 100 Lg/min. All
patients of Groups A and B were normotensive, whereas four
patients from Group C had been hypertensive previously and
were receiving therapy with /3-blockers, which kept their pres-
sure values in a normal range. All diabetics were receiving
insulin therapy twice daily and were on a diet containing 30 to
35 Kcal, 0.7 to 0.85 g protein/kg body wt, and 4 g NaCl. In
patients with clinical nephropathy (Group C), proteinuria was
assumed to be of diabetic origin if it occurred in a patient
diabetic for more than 10 years, with retinopathy, and without
reported history of other renal disease. Renal biopsy was not
performed. Clinical details are given in Table 1. Informed
consent was obtained from all normal and diabetic subjects.
Protocol
Twenty-four-hr urine collections were performed at home
during a period of normal physical activity, using thymol as a
preservative. Urine was analyzed for volume, glucose, and kept
at —20°C for no more than I month. Fasting blood samples were
obtained from a forearm vein in the morning. Blood was left
for 1 hr at room temperature, centrifugated at 3,000g for 30 mm
at 2 1°C, and blood cells were discarded. Serums were tested for
glucose and stored at —20°C for less than I month.
Purification of albumin
Albumin was purified from other serum and urinary proteins
by affinity chromatography with Affi-Gel Blue [18] (Bio-Rad,
Richmond, California, USA) in a 1.5 x 7 cm column equili-
brated with 0.05 mole/liter Tris-HC1, 0.1 mole/liter KC1 pH 7
buffer, applying I ml serum and about 300 ml urine to the
column. Other proteins were washed out with the starting buffer
until an extinction less than 0.0 1/280 nm was reached. Albumin
was eluted at room temperature with 0.05 mole/liter Tris-HC1,
1.5 mole/liter KC1 pH 7 buffer at constant 50 ml/hr flow rate,
dialyzed immediately against distilled water, and ultrafiltered
(PM-30 membranes, Amicon Corp., Danvers, Massachusetts,
USA) to reach an adequate protein concentration. Regeneration
for re-use was achieved by washing the gel with 10 column
volumes of 0.1 mole/liter Tris-HC1, 0.5 mole/liter NaCl pH 8.5
and subsequently with 10 column volumes of 0.1 mole/liter
acetate buffer pH 4.5.
Ultrathin isoelectric focusing and silver stain
Analytical ultrathin isoelectric focusing (IEF) of serum and
urinary albumin and GA was carried out in polyacrylamide slab
gels (T = 7%, C = 4%) precoated on glass plates (25 x 12 cm)
that had been pretreated for a few mm with 0.1% (v/v) Silane
A-l74 (Pharmacia, Uppsala, Sweden) in acetone [19]. Gaskets
were formed by cutting rectangles from parafllm, with two
layers giving approximately 240 im thickness [20]. Electropho-
resis was carried out at constant 10°C temperature using a LKB
Multiphor System (LKB, Bromma, Sweden). The polymeriza-
tion solution (10.6 ml) contained 12% (w/v) glycerol, 2.5% (v/v)
carrier ampholytes (LKB), 20 pd of a 25% (w/v) N,N,N',N'-
tetramethyl-aethylendiamin solution, and 50 1.d of a 10% (w/v)
ammonium persulfate solution. Each sample was run in two
ranges of ampholytes pH between 3.5 and 9.5 (linear) and
between 4 and 6 (non-linear). Unless specified otherwise, the
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Table 1. Clinical details and urinary excretion rates of albumin, immunoglobulin G, and J32-microglobulin in 11 normal subjects and in 25 Type
I diabetic patients, subdivided into three groups according to their urinary excretion rate of albumin
Age
Ideal
weight
.Duration of
diabetes Retinop
Blood glucose
Fasting Postprand
N Sex years % years N nmoleslliter
Normals 11 MS
F 6
31.5 93.8 — — 4.3 5.8
Group A 9 M 5
F 4
32.8 103.0 6.1 — 10.9 12.1
GroupB 11 M7F 4
43.7 94.3 5.7 — 10.7 11.1
Group C 5 M 2
F 3
49.8 94.2 3 mild
2 prolif
6.1 10.4
Abbreviations are: N, number of subjects; M, male; F, female; Retinop, retinopathy; Postprand, postprandial; UER, urinary excretion rate; Tot
prot, total proteins; IgG, Immunoglobulin G; /32-micro, f32-microglobulin; prolif, proliferative.
protein was applied directly to the gel with paper application
strips (3 MM, Whatman, Maidstone, England) in 20 to 40 d
aliquots to achieve a constant amount of protein (15 sg). In
some experiments, the amount of protein applied to gels ex-
ceeded 15 .tg greatly. Prefocusing was carried out for 1 hr at 350
V and the runs for 6 hr, increasing the voltage from 1000 to 2000
V at constant 25 mA and 130 W. Isoelectric points were
measured using a glass electrode (LKB 2117-111) at constant
10°C temperature.
Direct immunofixation [211 was carried out with cellulose
acetate strips (25 x 11 cm, Sepraphore III, Gelman Co., Ann
Arbor, Michigan, USA) soaked in dilutions of anti-albumin
antibodies (Dako A-OOl, Copenhagen, Denmark). After 60-mm
incubation at room temperature in a moist box, the strips were
removed and gels washed for 24 hr in a 0.9% (w/v) NaCl
solution with four changes, and twice in H20 for 30 mm.
Photochemical silver stain was performed by the method of
Merril [22].
Characterization of serum and urinary albumin
Bidimensional immunoelectrophoresis: Bidimensional im-
munoelectrophoresis directly from IEF gels was performed
according to Kessler [23] in a 1% agarose gel containing
anti-albumin antibodies (50 j.d) as first layer and anti-total serum
protein antibodies (400 p.l) as second layer.
Concanavalin A-Sepharose chromatography: Pooled sam-
pies of albumin purified from serum and urine of diabetic
patients were submitted to chromatography on Concanavalin
A-Sepharose (Pharmacia) in order to immobilize the fraction
with a high content of carbohydrates on the lectin [16]. Samples
(1 ml) were applied to a 1 x 2 cm column of Concanavalin
A-Sepharose, equilibrated with a 0.02 mole/liter Tris-HCI, 0.5
mole/liter NaC1 pH 7.4 buffer at a constant flow rate of 30 ml/hr.
Albumin not bound to Concanavalin A-Sepharose was eluted
with 80 ml of the starting buffer and the fraction bound to
Concanavalin A-Sepharose was eluted with 0.8 mole/liter
methyl-a-D-glucopyranoside in starting buffer. Fractions from
the lectin were dialyzed immediately against water, ultrafiltrat-
ed (Amicon PM 30 membranes), and then submitted to IEF as
described previously.
Fused rocket immunoelectrophoresis: Fused rocket im-
munoelectrophoresis [24] of every tube from the lectin was
performed in a 1% (wlv) agarose gel containing anti-albumin
antibodies as first layer (50 d) and anti-total serum proteins
(400 d) as second layer.
Amino acids analysis: Amino acids analysis of both
Concanavalin A-Sepharose bound and not bound fractions of
albumin was carried out after the hydrolysis with 6 moles/liter
HC1 at 100°C for 24 hr, using an amino acid analyzer (Model 120
B, Beckman, Fullerton, California, USA).
Quantitative assay for GA
Urinary and serum GA concentrations were evaluated in
triplicate by the thiobarbituric acid method as described [14,
25].
Other methods
Total urinary protein excretion was evaluated in triplicate
with the Coomassie dye-binding assay [26, 271 using crystal-
lized human serum albumin as standard. Serum and urinary
concentrations of albumin and immunoglobulins G (IgG) were
evaluated in triplicate with an Immunochemistry Analyzer [28]
(Beckman), using reagents supplied from Beckman. B2-
microglobulin (B2-micro) concentration was evaluated with a
radioimmunoassay [29] (Pharmacia). Creatinine was deter-
mined by Jaffe reaction, glucose by oxidase-peroxidase system.
For all spectrophotometric analysis, a Beckman Model 24 was
used. Excretion rates of total proteins, albumin, IgG, and
B2-micro were derived from concentration and timed urine
volume. Creatinine clearance was calculated applying the for-
mula corrected for 1.73 body surface area, where U and P
were respectively its urinary and plasma concentration.
Statistical methods
Statistical analysis was performed by using the one-way
analysis of variance [30]. The least squares method was used for
calculation of the correlation coefficient. Unless specified,
values are given as mean SEM.
Results
Serum and urinary protein concentration
Serum concentrations of albumin and IgG were not different
in normal subjects and in diabetic patients in Groups A and B.
Tube number
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Table 1. (Continued)
UER UER
lgG /32-micro Albumin clearance
Creatinine
clearanceTot prot Albumin
/iglml pg/min ,aglmin ng/min mI/mini] .73 m2 X IO mI/mini] .73 m2
41.2 4.4 2.4 75.6 0.94 104.2
(23.1—53.7) (2.6—6.8) (0.9—5.4) (15—88) (0.66—1.31) (93.6—120.2)
38.2 4.3 2.3 68.6 1.03 105.6
(16.2-62.4) (1.5—6.9) (1.9—4.1) (25—93) (0.4—1.33) (80—190)
108.7 31.9 8.9 85.6 7.49 103.4
(45.6—286.7) (10.8—99) (2.04—42.8) (36—100) (2.82—28.13) (84.2—131.8)
1201.5 666.9 120.4 1590 179.9 48.7
(252.7—3725.6) (109—2688) (14.6—280) (400—4430) (28.2—717.7) (6.7—102.7)
0
Fig. 2. Fused rocket immunoelectrophoresis of albumin purified from diabetic sera with Affi-Gel Blue and resolved further by Concanavalin
A-Sepharose in two fractions (without affinity 1 and with affinity 2 for Concanavalin A-Sepharose). Immunoelectrophoresis of each tube from
Concanavalin A-Sepharose was carried out in a 1% agarose gel containing in the first layer anti-albumin antibodies and in the second layer anti-total
serum proteins antibodies. Samples Ito 8 were diluted 1:10.
Patients of Group C showed a decreased concentration of both
proteins. Patients in Group B showed increased excretion rates
of albumin and IgG, if compared to normal subjects and Group
A, but showed normal excretion rates of B2-micro (Table I).
This pattern is consistent with diabetic nephropathy of func-
tional characteristics [2, 311. The excretion rates of all proteins
considered were significantly higher in Group C compared to
other Groups. reaching in three cases the typical values of the
nephrotic syndrome. In this last Group (C), the clearance of
creatinine was depressed as well.
Composition of serum albumin
In the conditions used herein, Affi-Gel Blue was found to be
highly selective for albumin (binding 95 to 98%, no other
contaminant detected) [321. All the single eluates obtained from
each serum were analyzed by ultrathin IEF associated with
silver stain [221. While serum albumin from normal subjects
consisted of a single, well-defined band with apI of 4.7, in afew
diabetic patients, in addition to this main band with a p1 of 4.7,
some others more anionic (p1 < 4.7) and more cationic (p1 >
— 3.5C
— 4.7
C
pT
9.0 L.. C
______ — 9.00
A B C
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4.7
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4.7) were found. As illustrated in Figure 1, these bands were
just appreciable in a few sera, while well marked in some others
(Tracks d and e), most of these bands were detectable between
4.7 and 7 (pH).
A pooled sample of serum albumin from diabetic patients was
chromatographated on a column of Concanavalin A-Sepharose
to achieve the separation of the highly glycosylated fraction of
albumin from the other less-substituted one [22]. In these
conditions, the lectin resolved the pooled sample of albumin in
two fractions, the first accounting for about 95% of the starting
material and the other one for the remaining 5%. At fused
rocket immunoelectrophoresis, both fractions gave a continu-
ous line of precipitation in the layer containing anti-albumin
antibodies, while no proteins were found in the second layer of
the gel enriched with antibodies against total serum proteins
(Fig. 2). When the two fractions from Concanavalin A-Sepha-
rose were re-analyzed by IEF, the pattern reported in Figure 3
(A and B) was observed: the first fraction consisted of a single
homogeneous band at 4.7 (pH), whereas all the microhetero-
geneous polydisperse bands covering a wide range of pls from
3.5 to 7 were found in the fraction with affinity for the lectin.
Apart from the most cationic, they all were detected also after
their direct immunofixation with anti-albumin antibodies (Fig.
3C), while other proteins used in another experiment as stan-
dards were lost rapidly during the extensive washings with a
Fig. 3. Isoelectric focusing of the fractions of albumin
pur jfied from diabetic sera and submitted to affinity
chromatography on Concanavalin A-Sepharose.
Symbols are: A, nut bound albumin; B, bound
albumin; and C, immunofixed sample B. Ultrathin lEE
was carried out in a linear range of Ampholines
between 3.5 and 9, and proteins were stained with the
silver method [221. One hundred gg of each sample
was applied. For track C, immunofixation was carried
out by the technique described by Confavreux et al
[21].
saline solution. By current criteria, the two peaks from
Concanavalin A-Sepharose represent two different subunits of
albumin, the second of which is highly glycosylated.
Composition of urinary albumin
When urinary albumin obtained from the same patients was
analyzed by IEF, we obtained the results shown in Figures 4, 5,
6, and 7. By taking, as reference, the main, unmodified albumin
at pH 4.7, one can see that urines of all normal subjects and
diabetics of both Groups A and B are enriched with a more
anionic albumin, migrating between 4.0 to 4.7 (pH). Further-
more, few subtle bands with a p1 higher than 4.7 are detectable
only in two or three tracks (Track 5 in Fig. 5, Track 7 in Fig. 6,
and Track 2 in Fig. 7). Concanavalin A-Sepharose resolved a
pooled sample of urinary albumin in two fractions, the first
accounting for about 80% of the starting material and the other
one (with affinity for the lectin) for the remaining 20%. The
bands with a p1 ranging from 4.0 to 4.7 were detected in the
second fraction with affinity for the lectin (Fig. 8A). That both
fractions were indeed albumin is shown finally in Figure 8B,
which is a bidimensional electrophoresis after the separation by
IEF in the first dimension. By current criteria, the fractions
from Concanavalin A-Sepharosc were classified as low modi-
fied (first) and highly glycosylated (second) albumin.
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Fig. 4. Ultrathin JEF of urinary albumin purified from 11 normal subjects by pseudo-ligand chromatography on Affi-Gel Blue [18]. IEF was carried
out in a non-linear range of Ampholine between 4 and 6, and proteins stained by the silver method of Merril [221. Fifteen g of protein were applied
for each track. In position 1, a sample of low glycosylated albumin was run (fraction 1 from Concanavalin A-Sepharose). Abbreviation: N, normal
subjects.
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Fig. 5. Ultrathin JEF of albumin purified from urines of nine diabetic patients with albumin UER < 10 gImin. In positions I and II, two samples
of low glycosylated albumin (fraction I from Concanavalin A-Sepharose) were run. IEF was carried out in a non-linear range between 4 and 6 (pH);
albumin was stained with the photochemical silver method of Merril [22]. Abbreviation: A, Group A patients.
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Fig. 6. Ultrathin JEF of albumin purified from urines of 11 diabetic patients with albumin UER between 10 and 100 g/min. In position 12, a sample
of low glycosylated albumin (fraction I from Concanavalin A-Sepharose) was run. IEF was carried Out in a non-linear range of Ampholine between
4 and 6 (pH); albumin was stained with the photochemical silver method of Merril [22]. Abbreviation: B, Group B patients.
C
5.8
p1
Fig. 7. JEF of albumin purified from urines of
five diabetic patients with albumin UER >
100 gImin. In positions I and 7, two
samples of low glycosylated albumin (fraction
I from Concanavalin A-Sepharose) were run.
IEF was carried out in a non-linear range of
4.1 Ampholine between 4 and 6; albumin was
stained with the photochemical silver method
4.0 of Merril [22]. Abbreviation: C, Group C
patients.
1 2 3 5 6 7
Discussion 3.5) to a more cationic (p1 7) value than the native protein (p1
4.7) [14, 33]. Yet unresolved is how the non-enzymatic glycos-
These data confirm that serum GA of diabetic patients can ylation of serum albumin can induce in its molecule an increase
exhibit a wider spectrum of pls, ranging from a more anionic (p1 in p1 up to 7. If anything, the condensation of sugar molecules
B C
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—
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Fig. 8A. Ultrathin JEF of albumin purified from urines of diabetic patients and resolved further by Concanavalin A-Sepharose in two fractions:
1) not bound, 2) bound to lectin. IEF was carried out in a non-linear range of Ampholine between 4 and 6, silver stained. B Bidimensional
electrophoresis of the same sample of urinary albumin before Concanavlin A-Sepharose. First dimension was IEF in a 4 to 6 Ampholine range.
on the c-amino side-chains of any protein (as in the case of GA)
should induce a decrease rather than an increase in p1. A
second issue is the apparent inability of the discrete amounts of
GA present in normal sera to alter their albumin pis. This fact
points to diabetes, rather than hyperglycemia per se, as the
main determinant of such a phenomenon. Actually, striking
differences in the composition of monosaccharides covalently
bound to the protein (including two unidentified peaks) between
normals and diabetics were found by gas chromatographic
analysis of GA [33], indicating that there are a few monosac-
charides in addition to glucose that can be bound by albumin.
Furthermore, some alterations of albumin pis very close to
those reported here were produced in vitro by incubating
albumin with monosaccharides other than glucose; those blood
concentrations in diabetic patients currently are unknown and
warrant further study. It is puzzling to see that urinary albumin
is enriched by many bands that have a more anionic charge than
its native protein, and at the same time are more glycosylated,
as suggested by their affinity toward Concanavalin A-
Sepharose. Such a result could be explained by a tubular
influence, since in normal conditions more than 90% of the
filtered albumin is reabsorbed by the tubular cells [34] and such
a process is enhanced further by cationization of albumin [35].
Therefore, chances are that normal albumin is reabsorbed more
avidly than the more anionic compound (p1 < 4.7), which
consequently would load the urinary pattern with many more
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albumins with pls between 4.0 and 4.7. In diabetic patients with
clinical nephropathy (Group C), the high concentration of
albumin in the ultrafiltrate could overload the reabsorptive
mechanisms, with consequent excretion into urines of high
amounts of albumin with a normal charge (Fig. 7) [341. Another
possible explanation could be an altered selectivity of the
glomerular basal membrane toward GAs with a p1 less than 4.7.
This would point to a crucial role of the carbohydrate(s)
covalently bound to this protein, in spite of the well-known
glomerular repulsion of all anionic charges [36, 37]. Should this
hypothesis prove correct, it would be reasonable then to stress
the role of the hyperfiltration of GA in the production of
diabetic microalbuminuria. This finding is in clear opposition
with the current theory that only cationic macromolecules cross
easily the negatively charged glomerular basal membrane,
thereby damaging the glomerulus [36, 371, the anionic ones
being repulsed strongly. In fact, the toxicity of albumin for both
glomerular and tubular structures increases almost linearly with
its p1 [38] beyond the value of 7. Unfortunately, we have no
reasonable hypothesis to account for this discrepancy, nor is
the contribution of our findings to the understanding of protein-
uria of diabetic origin clear. Therefore, the pathophysiological
significance of GA in the initiation and progression of diabetic
nephropathy merits further investigation, and it may be desir-
able that future studies of the mechanisms underlying the in
vivo deposition of macromolecules within the kidney use suc-
cessful physiological models. In this connection, one may recall
that in a recent study Melvin, Kim, and Michael showed that
the kidney deposition of IgG of diabetic rats was restricted to
the IgG4 band, the most anionic of IgG subclasses [39]. These
findings, along with the data reported here, might provide a
useful model for the understanding of the selectivity properties
of the glomerular wall in both normal and diseased kidneys.
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